To Top

Community

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Contribution
Innovation

Study Reveals New Medication Options for Opioid Dependency

PAO-M11-17-NI-040
FDA Approval

AstraZeneca’s Anti-Asthma FASENRA Wins FDA Approval

PAO-M11-17-NI-038
Innovation

Artificial Intelligence Powers New PAD Blood Test

PAO-M11-17-NI-037
Acquisition

Almac Expands Analytical Services with BioClin Laboratories Acquisition

PAO-M11-17-NI-033
Drug Development

Vetter’s Opens a New Office in South Korea

PAO-M11-17-NI-032
Drug Development

Small Molecule Cancer Combination Therapy Receives Second Patent

PAO-M11-17-NI-031
Investment

FUJIFILM Plans $1 Billion Capacity Expansion in U.S., U.K.

PAO-M11-17-NI-029
Drug Development

New Malaria Therapeutic Receives FDA Orphan Drug Designation

PAO-M11-17-NI-028
FDA

First Treatment for Rare Blood Disorder Approved by FDA

PAO-M11-17-NI-026
Drug Development

Compugen Advances Lead Anti-TIGIT Monoclonal Antibody to Manufacturing

PAO-M11-17-NI-025
Strategic Partnership

Dicerna and Boehringer Ingelheim Ink Deal to Develop Treatments for Chronic Liver Diseases

PAO-M11-17-NI-022
Clinical Research

CRO Pharmaceutical Product Development Wins NIH Contract for HIV Research

PAO-M11-17-NI-021
Acquisition

Mallinckrodt Expands Pipeline with Ocera Therapeutics Buy

PAO-M11-17-NI-020
Expanded Capacity

AbbVie Starts Up New Mammalian Cell-Culture Production Facility in Singapore

PAO-M11-17-NI-019
Expanded Capacity

Eli Lilly Expands Insulin Production Capacity in Indiana

PAO-M11-17-NI-018
CDMO

Alcami to Manufacture Darinaparsin

PAO-M11-17-NI-016
Research

Lung Cancer Research Institute Recipients Announced

PAO-M11-17-NI-013
Research

Fertility Experts: Embryos Travel Better Frozen

PAO-M11-17-NI-012
Drug Development

Amgen and Novartis Expand Collaboration to Prevent Alzheimer’s

PAO-M11-17-NI-009
Clinical Trials

FDA Lifts Clinical Hold on Cellectis Phase 1 Clinical Trials with UCART123 in AML and BPDCN

PR-M11-17-NI-001
Partnership

Parexel and MicroSoft to Develop New Cloud Technology

PAO-M11-17-NI-007
CRO

CitoxLab acquires Xenometrics, an American CRO specialized in preclinical assessment of new drug candidates

PR-M10-17-NI-010
CAR T

Mustang Bio Sends CAR T Cell Therapy Line to College

PAO-M11-17-NI-003
FDA Approval

Calquence, AstraZeneca’s BTK Inhibitor Approved by FDA

PAO-M11-17-NI-001
Vaccine

New Initiative to Accelerate Development of Universal Flu Vaccines Launches

PAO-M10-17-NI-046
Acquistion

Novartis Plans Acquisition of Advanced Accelerator Applications for $3.9 Billion

PAO-M10-17-NI-045
CRO

Factory CRO Acquires MileStone Research Organization, Builds North American Presence

PR-M10-17-NI-010
//Fix for text overflow in cards